ZNF304 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.381100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.976400E-01 |
Normal-vs-Stage2 |
7.830300E-02 |
Normal-vs-Stage3 |
1.91220000000936E-06 |
Normal-vs-Stage4 |
3.5355000038706E-09 |
Stage1-vs-Stage2 |
3.093700E-02 |
Stage1-vs-Stage3 |
2.34079999827941E-08 |
Stage1-vs-Stage4 |
3.85149689918762E-11 |
Stage2-vs-Stage3 |
8.100300E-02 |
Stage2-vs-Stage4 |
2.820500E-03 |
Stage3-vs-Stage4 |
1.009220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.916500E-03 |
Normal-vs-AfricanAmerican |
2.027600E-01 |
Normal-vs-Asian |
9.708200E-01 |
Caucasian-vs-AfricanAmerican |
9.702000E-01 |
Caucasian-vs-Asian |
5.662800E-01 |
AfricanAmerican-vs-Asian |
6.468600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.404550E-03 |
Normal-vs-Female |
3.497200E-01 |
Male-vs-Female |
4.074400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.218400E-01 |
Normal-vs-Age(41-60Yrs) |
2.215800E-01 |
Normal-vs-Age(61-80Yrs) |
1.837920E-03 |
Normal-vs-Age(81-100Yrs) |
3.517800E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.358000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.351000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.238600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.090100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.478970E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.129400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.424100E-04 |
Normal-vs-Grade 2 |
5.003200E-01 |
Normal-vs-Grade 3 |
3.52799999999709E-05 |
Normal-vs-Grade 4 |
2.58239984951558E-10 |
Grade 1-vs-Grade 2 |
4.182600E-03 |
Grade 1-vs-Grade 3 |
6.34199999999252E-05 |
Grade 1-vs-Grade 4 |
1.64740000530017E-08 |
Grade 2-vs-Grade 3 |
8.14179999975018E-07 |
Grade 2-vs-Grade 4 |
1.23120402761856E-11 |
Grade 3-vs-Grade 4 |
1.641970E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.468410E-01 |
Normal-vs-ccB subtype |
3.824100E-04 |
ccA subtype-vs-ccB subtype |
4.8169999999903E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.021950E-02 |
Normal-vs-N1 |
2.53159999996644E-06 |
N0-vs-N1 |
2.820100E-02 |
|
|